
Atul Anil Pabalkar
About Atul Anil Pabalkar
Data last updated:
Atul Anil Pabalkar is a Whole-Time Director at Biopharmax India Private Limited (since 2022). The companies operate in Engineering. Biopharmax India Private Limited reported revenue of ₹16.04 Cr (FY 2025). Earlier, Atul Anil Pabalkar was an Additional Director at Xact Engineering Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 02 Feb 2022 | 2006 | ₹16.04 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 22 Jul 2013 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Atul Anil Pabalkar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandhya Bindumadhav Deshpande | 08680466 | Biopharmax India Private Limited | Director |
| Sarel Chaim Chen Tov | 02205437 | Biopharmax India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atul Anil Pabalkar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atul Anil Pabalkar
Atul Anil Pabalkar currently holds 1 directorship: Biopharmax India Private Limited (Whole-Time Director, since 02 Feb 2022, revenue ₹16.04 Cr (FY 2025)).
Atul Anil Pabalkar was first appointed on 22 Jul 2013 as Additional Director at Xact Engineering Private Limited. The most recent appointment on record is 02 Feb 2022 at Biopharmax India Private Limited.
Atul Anil Pabalkar held 1 earlier board appointment: Xact Engineering Private Limited (Additional Director, from 22 Jul 2013).
The current boards of Atul Anil Pabalkar's companies include Sandhya Bindumadhav Deshpande (Biopharmax India Private Limited), Sarel Chaim Chen Tov (Biopharmax India Private Limited).